Description

Depreotide is a nove tumor tarcer, can be complexed with technetium-99m (99mTc-depreotide) for optimal imaging properties. 99mTc-depreotide somatostain receptor imaging has been playing an important role in medical diagnosis research[1].—Cancer-programmed cell death–C65H96N16O12S2—-[1]Rodrigues M, et al. 99mTc-depreotide scintigraphy versus 18F-FDG-PET in the diagnosis of radioiodine-negative thyroid cancer. J Clin Endocrinol Metab. 2006 Oct;91(10):3997-4000.  |[2]Halley A, et al. Efficiency of 18F-FDG and 99mTc-depreotide SPECT in the diagnosis of malignancy of solitary pulmonary nodules. Eur J Nucl Med Mol Imaging. 2005 Sep;32(9):1026-32. –161982-62-3–1357.69—-O=C([C@@H](NC([C@@H](N(C([C@@H](NC([C@@H](NC([C@@H](NC1=O)CCCCN)=O)C(C)C)=O)CCSCC(NC[C@H](N)C(N[C@@H](CCCCN)C(N[C@@H](CS)C(N[C@H](C(N)=O)CCCCN)=O)=O)=O)=O)=O)C)CC2=CC=CC=C2)=O)CC3=CC=C(C=C3)O)N[C@@H]1CC4=CNC5=CC=CC=C45–Cancer–10 mM in DMSO–Others—-Others–Peptides